clinic
sampl
evalu
mobil
analysi
platform
map
determin
platform
perform
detect
respiratori
virus
sampl
previous
character
use
clinic
revers
transcriptas
polymeras
chain
reaction
assay
percent
agreement
map
clinic
result
influenza
influenza
b
respiratori
syncyti
viru
rsv
neg
specimen
approxim
limit
detect
map
copiesassay
rsv
copiesassay
middl
east
respiratori
syndrom
coronaviru
acut
respiratori
ill
ari
caus
respiratori
virus
includ
influenza
virus
respiratori
syncyti
viru
rsv
affect
hundr
million
peopl
per
year
common
caus
viral
infect
respiratori
tract
human
berri
et
al
fendrick
et
al
zimmerman
et
al
year
approxim
million
case
ari
report
unit
state
direct
indirect
cost
approach
billion
annual
berri
et
al
fendrick
et
al
pandem
strain
influenza
season
variant
circul
season
serv
exampl
import
continu
respiratori
viru
surveil
effort
import
use
accur
inclus
diagnost
respiratori
viru
manag
flanneri
et
al
mahoni
mahoni
et
al
addit
given
emerg
middl
east
respiratori
syndrom
mer
coronaviru
subsequ
outbreak
thereof
middl
east
south
korea
import
diagnost
assay
respiratori
virus
rapid
deploy
near
point
care
poc
bhadra
et
al
raj
et
al
diagnost
platform
becom
common
capabl
detect
wide
array
respiratori
pathogen
zumla
et
al
evalu
novel
portabl
nearpoc
diagnost
platform
mobil
analysi
platform
map
assess
capabl
map
detect
influenza
influenza
b
rsv
extern
extract
clinic
sampl
establish
platform
limit
detect
lod
rsv
mer
clinic
matric
map
small
portabl
devic
integr
dispos
assayspecif
microfluid
card
fig
map
system
equip
set
subsystem
allow
automat
assay
process
includ
barcod
reader
input
specimen
microfluid
card
serial
number
b
motor
system
crush
liquid
reagent
diagnost
microbiolog
infecti
diseas
pack
command
c
pneumat
system
air
pressur
vacuum
move
liquid
within
card
via
peristalt
pump
use
vacuumactu
midstream
valv
specimen
thu
mix
variou
reagent
prepackag
card
lyophil
bead
move
sampl
reagent
microfluid
card
set
thermal
electr
cooler
allow
rapid
polymeras
chain
reaction
pcr
min
cycl
pcr
cycl
mix
sampl
reagent
perform
chamber
sandwich
thermoelectr
cool
devic
e
heat
element
maintain
temperatur
separ
hybrid
chamber
f
optic
system
includ
led
dye
excit
ccd
camera
imag
microarray
g
arm
processor
h
lcd
screen
keypad
microfluid
card
dispos
materi
requir
assay
includ
sampl
port
load
swab
b
wet
reagent
held
seal
blister
pack
c
lyophil
reagent
microarray
chip
microarray
chip
consist
spot
specif
dna
captur
probe
array
featur
featur
reserv
imag
align
allow
separ
spot
assay
pcr
product
digest
use
uracil
deglycosylas
hybrid
spot
microarray
wash
microarray
imag
digit
camera
led
illumin
imag
analyz
statist
interpret
via
onboard
analysi
softwar
entir
process
fulli
autom
result
present
positivenegativeinvalid
declar
screen
map
unit
multipl
primer
pairprob
combin
employ
analyt
design
offer
maximum
breadth
coverag
within
known
divers
target
viral
genu
total
clinic
respiratori
viru
sampl
evalu
includ
nasopharyng
swab
sampl
resuspend
vtm
n
nasal
wash
sampl
n
compos
true
posit
influenza
n
influenza
b
n
rsv
n
sampl
neg
analyt
n
sampl
acquir
institut
review
boardapprov
studi
adult
year
old
symptomat
respiratori
viru
infect
influenza
b
sampl
previous
test
posit
via
cepheid
xpert
flu
assay
cepheid
sunnyval
ca
cdc
human
influenza
viru
realtim
pcr
diagnost
panel
us
center
diseas
control
prevent
atlanta
ga
rsv
sampl
previous
test
posit
via
publish
realtim
pcr
assay
templeton
et
al
lod
experi
perform
rsv
mer
spike
viru
neg
clinic
matrix
avail
leftov
extract
initi
clinic
diagnost
test
util
avail
method
use
gener
new
extract
wast
aliquot
specimen
nucleic
acid
extract
use
either
arrow
viral
na
kit
nordiag
dsp
viral
mini
kit
qiagen
extract
nucleic
acid
load
onto
individu
map
assay
card
run
analyz
portabl
map
devic
accord
manufactur
instruct
primer
sequenc
target
organ
found
tabl
reagent
concentr
array
card
list
tabl
cycl
condit
follow
rt
step
min
hotstart
step
extend
touchdown
pcr
fast
pcr
cycl
follow
cycl
follow
cycl
follow
cycl
follow
cycl
follow
cycl
ramp
rate
approach
dampen
maximum
time
result
includ
nucleic
acid
extract
min
per
sampl
result
report
appear
autom
output
map
devic
sampl
gener
either
invalid
result
error
report
record
assay
failur
repeat
percent
agreement
map
standardofcar
revers
transcriptas
pcr
result
influenza
aposit
sampl
falseneg
result
assay
failur
result
invalid
error
report
percent
agreement
influenza
b
assay
failur
rsv
assay
failur
agreement
neg
sampl
rsvposit
result
assay
failur
lod
establish
copi
virusassay
rsv
mer
coronaviru
respect
previou
epidem
pandem
well
emerg
new
respiratori
viral
pathogen
highlight
need
accur
diagnost
platform
capabl
deploy
near
poc
zumla
et
al
perform
evalu
map
prototyp
determin
capabl
detect
identifi
influenza
influenza
b
rsv
perform
lod
experi
clinic
matrix
rsv
mer
percent
agreement
map
assay
result
predic
result
high
pathogen
evalu
exclud
invalid
assay
card
result
error
report
notest
instanc
lod
experi
rsv
mer
yield
accept
lod
ideal
evalu
would
includ
enough
posit
neg
sampl
calcul
sensit
specif
lower
bound
confid
interv
oppos
calcul
percent
agreement
howev
base
limit
number
array
card
avail
evalu
import
evalu
mani
posit
sampl
possibl
gaug
capabl
array
card
amplifi
pathogen
mer
ideal
evalu
would
includ
clinic
sampl
howev
given
rariti
difficulti
acquir
mer
posit
clinic
sampl
possibl
evalu
instanc
invalid
result
gener
almost
exclus
result
variabl
fluid
handl
array
card
could
overcom
modifi
technolog
util
fluid
handl
map
unit
addit
improv
map
unit
would
also
includ
combin
extract
amplif
process
one
instrument
would
bring
map
unit
closer
poc
diagnost
meet
assur
criteria
clearli
limit
studi
notabl
sensit
specif
assay
calcul
due
low
number
neg
sampl
evalu
futur
studi
would
ideal
includ
larg
increas
number
neg
sampl
evalu
well
perform
studi
prospect
manner
technolog
earli
stage
develop
yield
high
rate
invalid
test
result
percent
agreement
clinic
laboratori
method
approach
complet
test
technolog
show
promis
rapid
accur
deploy
diagnost
technolog
autom
detect
discrimin
multipl
pathogen
clinic
sampl
extract
